These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26993598)

  • 41. Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Wang H; Zhang X; Wang L; Zheng G; Du L; Yang Y; Dong Z; Liu Y; Qu A; Wang C
    J Surg Oncol; 2014 May; 109(6):574-9. PubMed ID: 24338523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic significance of the detection of peripheral blood CEACAM5mRNA-positive cells by real-time polymerase chain reaction in operable colorectal cancer.
    Vardakis N; Messaritakis I; Papadaki C; Agoglossakis G; Sfakianaki M; Saridaki Z; Apostolaki S; Koutroubakis I; Perraki M; Hatzidaki D; Mavroudis D; Georgoulias V; Souglakos J
    Clin Cancer Res; 2011 Jan; 17(1):165-73. PubMed ID: 21071514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case-controlled validation study of a blood-based seven-gene biomarker panel for colorectal cancer in Malaysia.
    Yip KT; Das PK; Suria D; Lim CR; Ng GH; Liew CC
    J Exp Clin Cancer Res; 2010 Sep; 29(1):128. PubMed ID: 20846378
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle.
    Moshayoff V; Faktor O; Laghi L; Celesti G; Peretz T; Keret D; Cohen D; Israeli E
    PLoS One; 2016; 11(7):e0159522. PubMed ID: 27441409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
    Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
    Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and evaluation of a colorimetric membrane-array method for the detection of circulating tumor cells in the peripheral blood of Taiwanese patients with colorectal cancer.
    Wang JY; Yeh CS; Chen YF; Wu CH; Hsieh JS; Huang TJ; Huang SY; Lin SR
    Int J Mol Med; 2006 May; 17(5):737-47. PubMed ID: 16596255
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improved real-time rt-PCR assays of two colorectal cancer peripheral blood mRNA biomarkers: a pilot study.
    Yadegarazari R; Hassanzadeh T; Majlesi A; Keshvari A; Monsef Esfahani A; Tootoonchi A; Shabab N; Saidijam M
    Iran Biomed J; 2013; 17(1):15-21. PubMed ID: 23279830
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer.
    Melson J; Li Y; Cassinotti E; Melnikov A; Boni L; Ai J; Greenspan M; Mobarhan S; Levenson V; Deng Y
    Int J Cancer; 2014 Jun; 134(11):2656-62. PubMed ID: 24288256
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer.
    Rahier JF; Druez A; Faugeras L; Martinet JP; Géhénot M; Josseaux E; Herzog M; Micallef J; George F; Delos M; De Ronde T; Badaoui A; D'Hondt L
    Clin Epigenetics; 2017; 9():53. PubMed ID: 28515797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Search for epithelial-specific mRNAs in peripheral blood of patients with colon cancer by RT-PCR.
    Solmi R; De Sanctis P; Zucchini C; Ugolini G; Rosati G; Del Governatore M; Coppola D; Yeatman TJ; Lenzi L; Caira A; Zanotti S; Taffurelli M; Carinci P; Valvassori L; Strippoli P
    Int J Oncol; 2004 Oct; 25(4):1049-56. PubMed ID: 15375555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of cytokeratin-20-positive cells in preoperative and postoperative blood samples from colorectal cancer patients by real-time RT-PCR.
    Šamija I; Lukač J; Mubrin MK; Kirac I; Kovačević D; Kusić Z
    Int J Biol Markers; 2013 Jun; 28(2):174-81. PubMed ID: 23558939
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical verification of plasma messenger RNA as novel noninvasive biomarker identified through bioinformatics analysis for lung cancer.
    Zhou D; Tang W; Liu X; An HX; Zhang Y
    Oncotarget; 2017 Jul; 8(27):43978-43989. PubMed ID: 28410204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients.
    Dandachi N; Balic M; Stanzer S; Halm M; Resel M; Hinterleitner TA; Samonigg H; Bauernhofer T
    J Mol Diagn; 2005 Nov; 7(5):631-7. PubMed ID: 16258162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
    Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
    Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel gene expression signature in peripheral blood mononuclear cells for early detection of colorectal cancer.
    Nichita C; Ciarloni L; Monnier-Benoit S; Hosseinian S; Dorta G; Rüegg C
    Aliment Pharmacol Ther; 2014 Mar; 39(5):507-17. PubMed ID: 24428642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification and validation of potential biomarkers for the detection of dysregulated microRNA by qPCR in patients with colorectal adenocarcinoma.
    Wu X; Xu X; Li S; Wu S; Chen R; Jiang Q; Liu H; Sun Y; Li Y; Xu Y
    PLoS One; 2015; 10(3):e0120024. PubMed ID: 25803870
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of long noncoding RNAs as potential novel diagnosis and prognosis biomarkers in colorectal cancer.
    Wang R; Du L; Yang X; Jiang X; Duan W; Yan S; Xie Y; Zhu Y; Wang Q; Wang L; Yang Y; Wang C
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2291-301. PubMed ID: 27591862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TLR2 and TLR4 polymorphisms influence mRNA and protein expression in colorectal cancer.
    Proença MA; de Oliveira JG; Cadamuro AC; Succi M; Netinho JG; Goloni-Bertolo EM; Pavarino ÉC; Silva AE
    World J Gastroenterol; 2015 Jul; 21(25):7730-41. PubMed ID: 26167073
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer-Type OATP1B3 mRNA in Extracellular Vesicles as a Promising Candidate for a Serum-Based Colorectal Cancer Biomarker.
    Morio H; Sun Y; Harada M; Ide H; Shimozato O; Zhou X; Higashi K; Yuki R; Yamaguchi N; Hofbauer JP; Guttmann-Gruber C; Anzai N; Akita H; Chiba K; Furihata T
    Biol Pharm Bull; 2018; 41(3):445-449. PubMed ID: 29491222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.